USE OF EPOTHILONE DERIVATIVES FOR THE TREATMENT OF HYPERPARATHYROIDISM

Details for Australian Patent Application No. 2003267751 (hide)

Owner BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITYAND AGRICULTURAL AND MECHANICAL COLLEGE

Inventors WOLTERING, Eugene, A.

Pub. Number AU-A-2003267751

PCT Number PCT/IB03/04514

PCT Pub. Number WO2004/035050

Priority 60/418,592 15.10.02 US

Filing date 13 October 2003

Wipo publication date 4 May 2004

International Classifications

A61K 031/427 - not condensed and containing further heterocyclic rings

A61P 005/00 Drugs for disorders of the endocrine system

A61P 005/18 Drugs for disorders of the endocrine system

A61P 035/00 Antineoplastic agents

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/418,592 15.10.02 US

10 June 2004 Application Open to Public Inspection

  Published as AU-A-2003267751

30 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267752-POWER TRAINER

2003267750-ASSOCIATION OF THE H2 HAPLOTYPE OF THE P2Y12 RECEPTOR WITH AN INCREASED RISK FOR THROMBOSIS AND PERIPHERAL ARTERIAL DISEASE